Renal insufficiency because of obstruction may not always be represented by dilated pelvicalyceal system. This may make diagnosis and thence the management very difficult with the present available investigative armamentarium. Experience and clinical acumen may help with a decision of empirical treatment in the form of stenting or nephrostomy in these cases. This may be diagnostic as well as curative of the renal failure. We present herewith three such challenging cases managed by us. We also have reviewed the literature as to the diagnosis and management of such cases.

We describe a very unusual presentation of misplaced Macroplastique injection. This incidentally showed up as bladder lesion and vaginal nodule during a tension-free vaginal tape surgery.

were treated by systemic chemotherapy with local therapy had longer PFS and OS than patients who were treated by systemic chemotherapy without local therapy (29.0 vs 6.9 months, p ¼ 0.04, 65.2 vs 33.3 months, p ¼ 0.08, respectively). Conclusions: Local therapy combined with systemic chemotherapy can be a treatment option for patients with oligometastatic NSCLC.

To determine if peripheral blood cells (PBC) apheresed following mobilization with chemotherapy and recombinant growth factor further enhances hematopoietic recovery over that achieved with autologous bone marrow (ABM) and recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) + 14 patients with metastatic solid tumors were supported by ABM and GM-CSF during the first course of high doses of cyclophosphamide, etoposide, and cisplatin (CVP) and by mobilized PBC with ABM and GM-CSF during the second course. Each patient served as his or her own control. Identical doses of CVP were given in both courses: cyclophosphamide 5.25 g/m2, etoposide 1200 mg/m2~ and cisplatin 165-180 mg/m2. PBC were collected on day 10

No abstract